TrialAsia-Pacific journal of clinical oncology2021

Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.

Tetsuhide Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.